Stocks and Investing
Stocks and Investing
Mon, April 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Maintained (AMGN) at Buy with Increased Target to $281 on, Apr 19th, 2021
Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $279 to $281 on, Apr 19th, 2021.
Matthew has made no other calls on AMGN in the last 4 months.
There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $230 on, Friday, March 5th, 2021
- Geoffrey Porges of "SVB Leerink" Maintained at Hold with Increased Target to $260 on, Friday, March 5th, 2021
These are the ratings of the 4 analyists that currently disagree with Matthew
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $275 on, Monday, April 5th, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $295 on, Wednesday, February 3rd, 2021
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $260 on, Wednesday, February 3rd, 2021
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $265 on, Wednesday, February 3rd, 2021
Contributing Sources